This dual signaling cascade promotes dendritic cell maturation and tumor antigen cross-presentation to CD8+ cytotoxic T lymphocytes (CTLs), while also recruiting pro-inflammatory immune subsets—including M1-polarized macrophages, neutrophils, and effector T cells, into tumor beds. Here, CD8A is linked to neoplasm.